Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
2.210
+0.110 (5.24%)
At close: Feb 21, 2025, 4:00 PM
2.260
+0.050 (2.26%)
After-hours: Feb 21, 2025, 7:47 PM EST
Intelligent Bio Solutions Employees
Intelligent Bio Solutions had 50 employees as of June 30, 2024. The number of employees decreased by 1 or -1.96% compared to the previous year.
Employees
50
Change (1Y)
-1
Growth (1Y)
-1.96%
Revenue / Employee
$60,628
Profits / Employee
-$213,940
Market Cap
11.67M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
INBS News
- 18 hours ago - Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter's Option to Purchase Additional Shares of Common Stock - GlobeNewsWire
- 2 days ago - Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock - GlobeNewsWire
- 2 days ago - Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 9 days ago - Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements - GlobeNewsWire
- 12 days ago - Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy - GlobeNewsWire
- 15 days ago - Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch - GlobeNewsWire
- 16 days ago - Intelligent Bio Solutions expects to achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales - GlobeNewsWire
- 22 days ago - Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade - GlobeNewsWire